Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.39 |
| ▸ | KDM1A | O60341 | 8/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21656916 | 1.00 | SLC6A3 (0.43) | SLC6A3HDAC6KDM1ASLC6A4MEN1 | |
| SCHEMBL21656944 | 0.95 | HDAC6 (0.39) | SLC6A3HDAC6KDM1ASLC6A4 | |
| SCHEMBL21656783 | 0.91 | SLC6A3 (0.44) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL21656650 | 0.89 | SLC6A3 (0.42) | SLC6A3KDM1ASLC6A4MEN1POLB | |
| SCHEMBL21628828 | 0.88 | SLC6A3 (0.47) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL21656880 | 0.88 | SLC6A3 (0.47) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL21628503 | 0.88 | SLC6A3 (0.42) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL21656775 | 0.88 | SLC6A3 (0.42) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL25083089 | 0.88 | SLC6A3 (0.42) | SLC6A3SLC6A4MEN1POLBGAA | |
| SCHEMBL21657049 | 0.86 | SLC6A3 (0.40) | SLC6A3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | SLC6A3 4040/4885HDAC6 2978/4885KDM1A 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.